vitiligo
VITILIGO
Vitiligo is an acquired, often familial, melanocytopenic disorder that produces focal depigmentation of the skin.
About half of the patients has onset of lesion before the age of 20.
It is a progressive disease wherein spontaneous repigmentation may occur within 6 months.
Precipitating factors include emotional stress, sunburn, chemical exposure, skin trauma, inflammation, irritation or rash that may precede the lesions by 2-3 months.
Lesions are white-colored macules or patches with well-defined borders and otherwise normal skin surface.

Surgical Intervention

Should only be used in non-progressive, small areas of inactive vitiligo

  • Eg epidermal blister grafting, autologous mini punch grafting, ultrathin epidermal sheet grafting, micropigmentation (tattooing), etc
  • May be an option if topical steroids or photochemotherapy fail to repigment
    • Surgery is usually limited to patients who have segmented or localized disease
    • May be used in some generalized patients
  • The following areas tend not to repigment well:
    • Forehead, hairline, dorsal fingers & ankles
  • Follow surgery w/ phototherapy

Editor's Recommendations
Most Read Articles
08 Oct 2017
Treatment with vismodegib does not appear to increase the risk of subsequent squamous cell carcinoma (SCC) in comparison with standard surgical treatment of basal cell carcinoma (BCC), a recent study suggests.
Stephen Padilla, 10 Oct 2017
Secukinumab has shown efficacy and safety for patients with extensive moderate-to-severe scalp psoriasis, according to a recent study.
09 Oct 2017
Use of voriconazole appears to increase the risk specifically for squamous cell carcinoma (SCC) in the allogeneic haematopoietic cell transplantation (HCT) population, according to a recent study.
27 Sep 2017
Poor sleep quality is not uncommon among patients with psoriatic disease, suggests a recent study. Poor sleep is associated with fatigue, anxiety and lower EQ-5D. It is also associated with actively inflamed joints in patients with psoriatic arthritis (PsA).